Smith & Nephew has announced that non-executive director Rick Medlock has decided to step down after three years at the medical technology group.
Source: Sharecast
Medlock, who joined in April 2020 and later became the chair of the audit committee, will not submit himself for re-election at the company's next annual general meeting.
He will be replaced by non-executive director Jez Maiden, who will be appointed chair of the audit committee from March 2024.
"The board would like to thank Rick for his commitment and contribution to the board and the company and to congratulate Jez on his new appointment," Smith & Nephew said in a statement.
Maiden, who currently also serves on the boards of Travis Perkins and Intertek, joined Smith & Nephew in 2023 after retiring as finance director at Croda International. He has previously headed up the audit committees of other life sciences and healthcare groups such as Synthomer and PZ Cussons.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
